-transparent.png){kind=logo}
The ability of human lymphocytes to produce soluble mediator(s) with thrombocyte aggregating activity (TAA) was investigated in an in vitro technique. Isolated human mononuclear cells were stimulated with phytohaemagglutinin or purified protein derivative of tuberculin. The supernatants were investigated for lymphokine activity in a leucocyte migration inhibitory factor assay. Supernatants were then tested for their ability to aggregate human thrombocytes, and in contrast to the results of previous studies, we were not able to demonstrate any TAA. Most likely, lymphokines with TAA are not involved in the thrombotic processes seen in human cell-mediated immune inflammatory reactions.
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
April 1976,
Acta allergologica,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
September 1979,
Schweizerische medizinische Wochenschrift,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
January 1984,
Laboratornoe delo,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
January 1985,
Laboratornoe delo,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
December 1979,
Thrombosis and haemostasis,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
January 1988,
Synapse (New York, N.Y.),
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
February 2014,
Neuroscience letters,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
July 1983,
The Journal of clinical investigation,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
December 1982,
Journal of lipid research,
P Oxholm, and
K Winther, and
K Bendtzen, and
G Bendixen
January 1980,
International archives of allergy and applied immunology,
